JP2003505413A - Ｃｎｓおよび眼疾患におけるアゼチジン化合物 - Google Patents

Ｃｎｓおよび眼疾患におけるアゼチジン化合物

Info

Publication number
JP2003505413A
JP2003505413A JP2001511908A JP2001511908A JP2003505413A JP 2003505413 A JP2003505413 A JP 2003505413A JP 2001511908 A JP2001511908 A JP 2001511908A JP 2001511908 A JP2001511908 A JP 2001511908A JP 2003505413 A JP2003505413 A JP 2003505413A
Authority
JP
Japan
Prior art keywords
compound
use according
trifluoromethyl
azetidine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001511908A
Other languages
English (en)
Japanese (ja)
Inventor
マイク フレデリック スナイプ，
Original Assignee
バーナリス リサーチ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バーナリス リサーチ リミテッド filed Critical バーナリス リサーチ リミテッド
Publication of JP2003505413A publication Critical patent/JP2003505413A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2001511908A 1999-07-23 2000-07-21 Ｃｎｓおよび眼疾患におけるアゼチジン化合物 Withdrawn JP2003505413A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9917384.1A GB9917384D0 (en) 1999-07-23 1999-07-23 Chemical compounds-III
GB9917384.1 1999-07-23
PCT/GB2000/002817 WO2001007022A2 (fr) 1999-07-23 2000-07-21 Composes chimiques iii

Publications (1)

Publication Number Publication Date
JP2003505413A true JP2003505413A (ja) 2003-02-12

Family

ID=10857862

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001511908A Withdrawn JP2003505413A (ja) 1999-07-23 2000-07-21 Ｃｎｓおよび眼疾患におけるアゼチジン化合物

Country Status (5)

Country Link
EP (1) EP1196165A2 (fr)
JP (1) JP2003505413A (fr)
AU (1) AU6006000A (fr)
GB (1) GB9917384D0 (fr)
WO (1) WO2001007022A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509860A (ja) * 2008-11-24 2012-04-26 エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ 皮質のカテコールアミン作動性神経伝達のモジュレーターとして有用な新規な３−フェニル−アゼチジン誘導体
JP2017530955A (ja) * 2014-09-03 2017-10-19 ザ ユニバーシティ オブ バーミンガム 頭蓋内圧上昇の治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB872447A (en) * 1958-12-23 1961-07-12 Lepetit Spa 1-carbamyl-3-substituted azetidines
AU2178099A (en) * 1998-01-23 1999-08-09 Vernalis Research Limited Azetidinecarboxamide derivatives for treating cns disorders

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012509860A (ja) * 2008-11-24 2012-04-26 エヌエスエイビー、フィリアル アヴ ノイロサーチ スウェーデン エービー、スヴェーリエ 皮質のカテコールアミン作動性神経伝達のモジュレーターとして有用な新規な３−フェニル−アゼチジン誘導体
JP2017530955A (ja) * 2014-09-03 2017-10-19 ザ ユニバーシティ オブ バーミンガム 頭蓋内圧上昇の治療
US10835579B2 (en) 2014-09-03 2020-11-17 Invex Therapeutics Ltd. Elevated intracranial pressure treatment
US11738067B2 (en) 2014-09-03 2023-08-29 Invex Therapeutics Ltd. Elevated intracranial pressure treatment

Also Published As

Publication number Publication date
WO2001007022A3 (fr) 2001-06-14
EP1196165A2 (fr) 2002-04-17
GB9917384D0 (en) 1999-09-22
AU6006000A (en) 2001-02-13
WO2001007022A2 (fr) 2001-02-01

Similar Documents

Publication Publication Date Title
US7217705B2 (en) Combination of a CB1 receptor antagonist and of a product which activates dopaminergic neurotransmission in the brain, the pharmaceutical compositions comprising them and their use in the treatment of parkinson's disease
EP1617839B1 (fr) Utilisation de derives d'azetidinecarboxamide a des fins therapeutiques
TWI591058B (zh) ［３－（１－（１ｈ－咪唑－４－基）乙基）－２－甲基苯基］甲醇之酯類前藥
JPH09507216A (ja) ５−（２−イミダゾリニルアミノ）ベンゾイミダゾール誘導体、それらの製法及びα−２−アドレノセプター作動剤としてのそれらの用途
TW200803839A (en) Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia
WO1999020620A1 (fr) Derive d'isoquinoleine et medicament
EA009732B1 (ru) Диарильные и арилгетероарильные производные мочевины в качестве модуляторов 5-ht-рецептора серотонина, пригодные для профилактики и лечения связанных с ним заболеваний
AU2019253831B2 (en) Compositions and methods for treating neurodegenerative diseases
JP2006525299A (ja) アゼチジンカルボキサミド誘導体及びｃｂ１レセプター媒介障害の治療におけるその使用
KR101471585B1 (ko) 트라마돌 및 콕시브의 공결정
EP1148881A1 (fr) UTILISATION DE DERIVES DE PYRIDAZINO [4,5-(b)]-INDOLE-1-ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AUX MALADIES LIEES AU DYSFONCTIONNEMENT DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
WO2002045750A1 (fr) Medicaments combines
JP2003505414A (ja) Ｃｎａおよび眼疾患におけるアゼチジン化合物
JP2003505413A (ja) Ｃｎｓおよび眼疾患におけるアゼチジン化合物
JP2003505418A (ja) Ｃｎｓ障害の処置のためのアゼチジンカルボキサミド誘導体
JPH05504146A (ja) シクロアルキル置換グルタルアミド降圧剤
US6514961B1 (en) Azetidinecarboxamide derivatives for the treatment of CNS disorders
JP4542264B2 (ja) Ｃｎｓ障害を処置するためのアゼチジンカルボキサミド誘導体
NL2031331B1 (en) Transmucosal delivery of a short-acting psychedelic compound
JP2000511193A (ja) 高血圧の処置法
JP2003246732A (ja) １，２−エタンジオール誘導体またはその塩を含有する神経断裂治療剤
JP2001503022A (ja) アリールアルカノイルピリダジン誘導体

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20071002